| Authors | Ajay K Gopal, Brad S Kahl, Christopher R Flowers, Peter Martin, Stephen M Ansell, Esteban Abella-Dominicis, Brian Koh, Wei Ye, Paul M Barr, Gilles A Salles, Jonathan W Friedberg |
| Journal | Blood
(Blood)
Vol. 129
Issue 22
Pg. 3037-3039
(06 01 2017)
ISSN: 1528-0020 [Electronic] United States |
| PMID | 28325864
(Publication Type: Clinical Trial, Phase II, Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Monoclonal, Murine-Derived
- Purines
- Quinazolinones
- R-CHOP protocol
- Rituximab
- Vincristine
- Doxorubicin
- Cyclophosphamide
- Prednisone
- idelalisib
|
| Topics |
- Antibodies, Monoclonal, Murine-Derived
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects)
- Cyclophosphamide
(administration & dosage, adverse effects)
- Disease-Free Survival
- Doxorubicin
(administration & dosage, adverse effects)
- Female
- Humans
- Lymphoma, Follicular
(drug therapy, mortality, pathology)
- Male
- Prednisone
(administration & dosage, adverse effects)
- Purines
(administration & dosage, adverse effects)
- Quinazolinones
(administration & dosage, adverse effects)
- Recurrence
- Rituximab
- Survival Rate
- Vincristine
(administration & dosage, adverse effects)
|
